Works matching AU Hida, Toyoaki

Results: 82

Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation.

Published in:

2017

By:

Yuko Oya;
Tatsuya Yoshida;
Hiroaki Kuroda;
Junichi Shimizu;
Yoshitsugu Horio;
Yukinori Sakao;
Yoshitaka Inaba;
Toyoaki Hida;
Yasushi Yatabe;
Oya, Yuko;
Yoshida, Tatsuya;
Kuroda, Hiroaki;
Shimizu, Junichi;
Horio, Yoshitsugu;
Sakao, Yukinori;
Inaba, Yoshitaka;
Hida, Toyoaki;
Yatabe, Yasushi

Publication type:

journal article

Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 218, doi. 10.1007/s10147-011-0277-4

By:

Ogawa, Shizu;
Horio, Yoshitsugu;
Yatabe, Yasusi;
Fukui, Takayuki;
Ito, Simon;
Hasegawa, Yoshinori;
Mitsudomi, Tetsuya;
Hida, Toyoaki

Publication type:

Article

Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLC.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-024-00781-w

By:

Shirasawa, Masayuki;
Yoshida, Tatsuya;
Matsutani, Takaji;
Takeyasu, Yuki;
Goto, Naoko;
Yagishita, Shigehiro;
Kitano, Shigehisa;
Kuroda, Hiroaki;
Hida, Toyoaki;
Kurata, Takayasu;
Ohe, Yuichiro

Publication type:

Article

Pulmonary infections mimicking malignancy on bronchoscopy: A retrospective single‐center study in Japan.

Published in:

Journal of General & Family Medicine, 2021, v. 22, n. 1, p. 38, doi. 10.1002/jgf2.383

By:

Itoh, Naoya;
Shimizu, Junichi;
Murakami, Hiromi;
Hida, Toyoaki

Publication type:

Article

Palmoplantar Pustulosis Caused by Immune-Checkpoint Inhibitors.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e829, doi. 10.1016/j.cllc.2021.04.002

By:

Furuta, Hiromi;
Kato, Seiichi;
Masago, Katsuhiro;
Hida, Toyoaki

Publication type:

Article

Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.

Published in:

2018

By:

Hida, Toyoaki;
Kaji, Reiko;
Satouchi, Miyako;
Ikeda, Norihiko;
Horiike, Atsushi;
Nokihara, Hiroshi;
Seto, Takashi;
Kawakami, Tomohisa;
Nakagawa, Shintaro;
Kubo, Toshio

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer.

Published in:

2016

By:

Nishio, Makoto;
Goto, Koichi;
Chikamori, Kenichi;
Hida, Toyoaki;
Katakami, Nobuyuki;
Maemondo, Makoto;
Ohishi, Norihisa;
Tamura, Tomohide

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non--Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2016, v. 17, n. 1, p. 24, doi. 10.1016/j.cllc.2015.07.001

By:

Makoto Nishio;
Koichi Goto;
Kenichi Chikamori;
Toyoaki Hida;
Nobuyuki Katakami;
Makoto Maemondo;
Norihisa Ohishi;
Tomohide Tamura

Publication type:

Article

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement‑positive non‑small cell lung cancer: A case report.

Published in:

2018

By:

Oya, Yuko;
Yoshida, Tatsuya;
Uemura, Takehiro;
Murakami, Yoshiko;
Inaba, Yoshitaka;
Hida, Toyoaki

Publication type:

Case Study

Ectopic expression of c- kit in small-cell lung cancer.

Published in:

International Journal of Cancer, 1994, v. 57, p. 108, doi. 10.1002/ijc.2910570723

By:

Hida, Toyoaki;
Ueda, Ryuzo;
Sekido, Yoshitaka;
Hibi, Kenji;
Matsuda, Ryohei;
Ariyoshi, Yutaka;
Sugiura, Takahiko;
Takahash, Takashi;
Takahashi, Toshitade

Publication type:

Article

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157

By:

Saka, Hideo;
Nishio, Makoto;
Hida, Toyoaki;
Nakagawa, Kazuhiko;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Takahashi, Toshiaki;
Horinouchi, Hidehito;
Takenoyama, Mitsuhiro;
Katakami, Nobuyuki;
Tanaka, Hiroshi;
Takeda, Koji;
Satouchi, Miyako;
Isobe, Hiroshi;
Maemondo, Makoto;
Goto, Koichi;
Hirashima, Tomonori;
Minato, Koichi;
Yada, Nobumichi

Publication type:

Article

Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 614, doi. 10.1093/jjco/hyz039

By:

Niho, Seiji;
Hosomi, Yukio;
Okamoto, Hiroaki;
Nihei, Keiji;
Tanaka, Hiroshi;
Hida, Toyoaki;
Umemura, Shigeki;
Goto, Koichi;
Akimoto, Tetsuo;
Ohe, Yuichiro

Publication type:

Article

Salvage surgery for small cell lung cancer after chemoradiotherapy.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 4, p. 389, doi. 10.1093/jjco/hyz010

By:

Nakanishi, Keita;
Mizuno, Tetsuya;
Sakakura, Noriaki;
Kuroda, Hiroaki;
Shimizu, Junichi;
Hida, Toyoaki;
Yatabe, Yasushi;
Sakao, Yukinori

Publication type:

Article

Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.

Published in:

2022

By:

Nishio, Makoto;
Kato, Terufumi;
Toyozawa, Ryo;
Hida, Toyoaki

Publication type:

journal article

Savolitinib ± Osimertinib in Japanese Patients with Advanced Solid Malignancies or EGFRm NSCLC: Ph1b TATTON Part C.

Published in:

2021

By:

Yoh, Kiyotaka;
Hirashima, Tomonori;
Saka, Hideo;
Kurata, Takayasu;
Ohe, Yuichiro;
Hida, Toyoaki;
Mellemgaard, Anders;
Verheijen, Remy B.;
Ou, Xiaoling;
Ahmed, Ghada F.;
Hayama, Manabu;
Sugibayashi, Ko;
Oxnard, Geoffrey R.

Publication type:

journal article

Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.

Published in:

Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 4, p. 527, doi. 10.1007/s00432-009-0685-2

By:

Yoshida, Kimihide;
Yatabe, Yasushi;
Jangchul Park;
Shizu Ogawa;
Ji Young Park;
Shimizu, Junichi;
Horio, Yoshitsugu;
Matsuo, Keitaro;
Mitsudomi, Tetsuya;
Hida, Toyoaki

Publication type:

Article

Asthma caused by durvalumab after chemoradiotherapy in two patients with non‐small cell lung cancer.

Published in:

Respirology Case Reports, 2021, v. 9, n. 9, p. 1, doi. 10.1002/rcr2.835

By:

Uemura, Takehiro;
Fukumitsu, Kensuke;
Maeno, Ken;
Fukuda, Satoshi;
Onuki, Tomohiro;
Kanemitsu, Yoshihiro;
Oguri, Tetsuya;
Niimi, Akio;
Hida, Toyoaki

Publication type:

Article

Successful bronchial arterial infusion chemotherapy combined with radiotherapy for an endobronchial metastasis after resection of small cell lung cancer.

Published in:

Respirology Case Reports, 2021, v. 9, n. 4, p. 1, doi. 10.1002/rcr2.728

By:

Horio, Yoshitsugu;
Sato, Yozo;
Tachibana, Hiroyuki;
Hosoda, Waki;
Shimizu, Junichi;
Hida, Toyoaki

Publication type:

Article

Successful salvage surgery following multimodal therapy in a patient who harboured ALK-rearranged advanced lung adenocarcinoma with multiple organ metastases.

Published in:

Respirology Case Reports, 2019, v. 7, n. 7, p. 1, doi. 10.1002/rcr2.451

By:

Yoshitsugu Horio;
Tetsuya Mizuno;
Yukinori Sakao;
Yoshitaka Inaba;
Yasushi Yatabe;
Toyoaki Hida

Publication type:

Article

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.

Published in:

Respirology, 2008, v. 13, n. 4, p. 510, doi. 10.1111/j.1440-1843.2008.01302.x

By:

Shimizu, Junichi;
Horio, Yoshitsugu;
Osada, Hirotaka;
Hida, Toyoaki;
Hasegawa, Yoshinori;
Shimokata, Kaoru;
Takahashi, Takashi;
Sekido, Yoshitaka;
Yatabe, Yasushi

Publication type:

Article

Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.

Published in:

Carcinogenesis, 2012, v. 33, n. 7, p. 1277, doi. 10.1093/carcin/bgs154

By:

Shinjo, Keiko;
Okamoto, Yasuyuki;
An, Byonggu;
Yokoyama, Toshihiko;
Takeuchi, Ichiro;
Fujii, Makiko;
Osada, Hirotaka;
Usami, Noriyasu;
Hasegawa, Yoshinori;
Ito, Hidemi;
Hida, Toyoaki;
Fujimoto, Nobukazu;
Kishimoto, Takumi;
Sekido, Yoshitaka;
Kondo, Yutaka

Publication type:

Article

Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population.

Published in:

Carcinogenesis, 2010, v. 31, n. 4, p. 660, doi. 10.1093/carcin/bgq021

By:

Park, Ji Young;
Matsuo, Keitaro;
Suzuki, Takeshi;
Ito, Hidemi;
Hosono, Satoyo;
Kawase, Takakazu;
Watanabe, Miki;
Oze, Isao;
Hida, Toyoaki;
Yatabe, Yasushi;
Mitsudomi, Tetsuya;
Takezaki, Toshiro;
Tajima, Kazuo;
Tanaka, Hideo

Publication type:

Article

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.

Published in:

2019

By:

Ahn, Myung‐Ju;
Tsai, Chun‐Ming;
Shepherd, Frances A.;
Bazhenova, Lyudmila;
Sequist, Lecia V.;
Hida, Toyoaki;
Yang, James C. H.;
Ramalingam, Suresh S.;
Mitsudomi, Tetsuya;
Jänne, Pasi A.;
Mann, Helen;
Cantarini, Mireille;
Goss, Glenwood;
Ahn, Myung-Ju;
Tsai, Chun-Ming

Publication type:

journal article

Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.

Published in:

2017

By:

Tanaka, Kosuke;
Hida, Toyoaki;
Oya, Yuko;
Yoshida, Tatsuya;
Shimizu, Junichi;
Mizuno, Tetsuya;
Kuroda, Hiroaki;
Sakakura, Noriaki;
Yoshimura, Kenichi;
Horio, Yoshitsugu;
Sakao, Yukinori;
Yatabe, Yasushi

Publication type:

journal article

Weak-evidence Fusion Candidates Detected by a FusionPlex Assay Using the Ion Torrent System.

Published in:

In Vivo, 2021, v. 35, n. 2, p. 993, doi. 10.21873/invivo.12342

By:

SHIRO FUJITA;
KATSUHIRO MASAGO;
EIICHI SASAKI;
SATOSHI TSUKUSHI;
YOSHITSUGU HORIO;
HIROAKI KURODA;
TOYOAKI HIDA

Publication type:

Article

hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.

Published in:

Journal of Human Genetics, 2009, v. 54, n. 12, p. 739, doi. 10.1038/jhg.2009.108

By:

Okasaka, Toshiki;
Matsuo, Keitaro;
Suzuki, Takeshi;
Ito, Hidemi;
Hosono, Satoyo;
Kawase, Takakazu;
Watanabe, Miki;
Yatabe, Yasushi;
Hida, Toyoaki;
Mitsudomi, Tetsuya;
Tanaka, Hideo;
Yokoi, Kohei;
Tajima, Kazuo

Publication type:

Article

Gefitinib for the treatment of non-small-cell lung cancer.

Published in:

Expert Review of Anticancer Therapy, 2009, v. 9, n. 1, p. 17, doi. 10.1586/14737140.9.1.17

By:

Hida, Toyoaki;
Ogawa, Shizu;
Jang Chul Park;
Shimizu, Junichi;
Horio, Yoshitsugu;
Yoshida, Kimihilde

Publication type:

Article

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

Published in:

Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144

By:

Satouchi, Miyako;
Nosaki, Kaname;
Takahashi, Toshiaki;
Nakagawa, Kazuhiko;
Aoe, Keisuke;
Kurata, Takayasu;
Sekine, Akimasa;
Horiike, Atsushi;
Fukuhara, Tatsuro;
Sugawara, Shunichi;
Umemura, Shigeki;
Saka, Hideo;
Okamoto, Isamu;
Yamamoto, Nobuyuki;
Sakai, Hiroshi;
Kishi, Kazuma;
Katakami, Nobuyuki;
Horinouchi, Hidehito;
Hida, Toyoaki;
Okamoto, Hiroaki

Publication type:

Article

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study.

Published in:

Cancer Science, 2021, v. 112, n. 4, p. 1556, doi. 10.1111/cas.14826

By:

Seto, Takashi;
Ohashi, Kadoaki;
Sugawara, Shunichi;
Nishio, Makoto;
Takeda, Masayuki;
Aoe, Keisuke;
Moizumi, Sanae;
Nomura, Satoshi;
Tajima, Takeshi;
Hida, Toyoaki

Publication type:

Article

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4442, doi. 10.1111/cas.14605

By:

Kagawa, Yusuke;
Furuta, Hiromi;
Uemura, Takehiro;
Watanabe, Naohiro;
Shimizu, Junichi;
Horio, Yoshitsugu;
Kuroda, Hiroaki;
Inaba, Yoshitaka;
Kodaira, Takeshi;
Masago, Katsuhiro;
Fujita, Shiro;
Niimi, Akio;
Hida, Toyoaki

Publication type:

Article

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647

By:

Satouchi, Miyako;
Nosaki, Kaname;
Takahashi, Toshiaki;
Nakagawa, Kazuhiko;
Aoe, Keisuke;
Kurata, Takayasu;
Sekine, Akimasa;
Horiike, Atsushi;
Fukuhara, Tatsuro;
Sugawara, Shunichi;
Umemura, Shigeki;
Saka, Hideo;
Okamoto, Isamu;
Yamamoto, Nobuyuki;
Sakai, Hiroshi;
Kishi, Kazuma;
Katakami, Nobuyuki;
Horinouchi, Hidehito;
Hida, Toyoaki;
Okamoto, Hiroaki

Publication type:

Article

Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

Published in:

Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576

By:

Seto, Takashi;
Hayashi, Hidetoshi;
Satouchi, Miyako;
Goto, Yasushi;
Niho, Seiji;
Nogami, Naoyuki;
Hida, Toyoaki;
Takahashi, Toshiaki;
Sakakibara‐Konishi, Jun;
Morise, Masahiro;
Nagasawa, Takashi;
Suzuki, Mie;
Ohkura, Masayuki;
Fukuhara, Kei;
Thurm, Holger;
Peltz, Gerson;
Nishio, Makoto

Publication type:

Article

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis.

Published in:

Cancer Science, 2019, v. 110, n. 9, p. 2884, doi. 10.1111/cas.14120

By:

Hirashima, Tomonori;
Satouchi, Miyako;
Hida, Toyoaki;
Nishio, Makoto;
Kato, Terufumi;
Sakai, Hiroshi;
Imamura, Fumio;
Kiura, Katsuyuki;
Okamoto, Isamu;
Kasahara, Kazuo;
Uchida, Hirohiko;
Vowler, Sarah L.;
Mitsudomi, Tetsuya

Publication type:

Article

Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9.

Published in:

Cancer Science, 2018, v. 109, n. 9, p. 2863, doi. 10.1111/cas.13721

By:

Hida, Toyoaki;
Seto, Takashi;
Horinouchi, Hidehito;
Maemondo, Makoto;
Takeda, Masayuki;
Hotta, Katsuyuki;
Hirai, Fumihiko;
Kim, Young Hak;
Matsumoto, Shingo;
Ito, Masayuki;
Ayukawa, Koichi;
Tokushige, Kota;
Yonemura, Masataka;
Mitsudomi, Testuya;
Nishio, Makoto

Publication type:

Article

ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

Published in:

Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651

By:

Azuma, Koichi;
Nishio, Makoto;
Hayashi, Hidetoshi;
Kiura, Katsuyuki;
Satouchi, Miyako;
Sugawara, Shunichi;
Hida, Toyoaki;
Iwamoto, Yasuo;
Inoue, Akira;
Takeda, Koji;
Ikeda, Satoshi;
Nakagawa, Tomoki;
Takeda, Kentaro;
Asahina, Seitaro;
Komatsu, Kanji;
Morita, Satoshi;
Fukuoka, Masahiro;
Nakagawa, Kazuhiko

Publication type:

Article

Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial.

Published in:

Cancer Science, 2018, v. 109, n. 6, p. 1930, doi. 10.1111/cas.13623

By:

Akamatsu, Hiroaki;
Katakami, Nobuyuki;
Okamoto, Isamu;
Kato, Terufumi;
Kim, Young Hak;
Imamura, Fumio;
Shinkai, Masaharu;
Hodge, Rachel A.;
Uchida, Hirohiko;
Hida, Toyoaki

Publication type:

Article

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

Published in:

Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225

By:

Hida, Toyoaki;
Nishio, Makoto;
Nogami, Naoyuki;
Ohe, Yuichiro;
Nokihara, Hiroshi;
Sakai, Hiroshi;
Satouchi, Miyako;
Nakagawa, Kazuhiko;
Takenoyama, Mitsuhiro;
Isobe, Hiroshi;
Fujita, Shiro;
Tanaka, Hiroshi;
Minato, Koichi;
Takahashi, Toshiaki;
Maemondo, Makoto;
Takeda, Koji;
Saka, Hideo;
Goto, Koichi;
Atagi, Shinji;
Hirashima, Tomonori

Publication type:

Article

Pharmacologic study ( JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy.

Published in:

Cancer Science, 2016, v. 107, n. 11, p. 1642, doi. 10.1111/cas.13066

By:

Hida, Toyoaki;
Nakagawa, Kazuhiko;
Seto, Takashi;
Satouchi, Miyako;
Nishio, Makoto;
Hotta, Katsuyuki;
Takahashi, Toshiaki;
Ohe, Yuichiro;
Takeda, Koji;
Tatsuno, Masahiro;
Asakawa, Takashi;
Shimada, Tadashi;
Tanaka, Tomohiro;
Tamura, Tomohide

Publication type:

Article

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3.

Published in:

Cancer Science, 2015, v. 106, n. 9, p. 1202, doi. 10.1111/cas.12723

By:

Kato, Terufumi;
Yoshioka, Hiroshige;
Okamoto, Isamu;
Yokoyama, Akira;
Hida, Toyoaki;
Seto, Takashi;
Kiura, Katsuyuki;
Massey, Dan;
Seki, Yoko;
Yamamoto, Nobuyuki

Publication type:

Article

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Published in:

Cancer Science, 2011, v. 102, n. 4, p. 845, doi. 10.1111/j.1349-7006.2010.01839.x

By:

Hida, Toyoaki;
Tamiya, Motohiro;
Nishio, Makoto;
Yamamoto, Nobuyuki;
Hirashima, Tomonori;
Horai, Takeshi;
Tanii, Hiromi;
Shi, Michael M.;
Kobayashi, Ken;
Horio, Yoshitsugu

Publication type:

Article

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.

Published in:

Cancer Science, 2007, v. 98, n. 3, p. 438, doi. 10.1111/j.1349-7006.2006.00386.x

By:

Taniguchi, Tetsuo;
Karnan, Sivasundaram;
Fukui, Takayuki;
Yokoyama, Toshihiko;
Tagawa, Hiroyuki;
Yokoi, Kohei;
Ueda, Yuichi;
Mitsudomi, Tetsuya;
Horio, Yoshitsugu;
Hida, Toyoaki;
Yatabe, Yasushi;
Seto, Masao;
Sekido, Yoshitaka

Publication type:

Article

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.

Published in:

Cancer Science, 2006, v. 97, n. 5, p. 387, doi. 10.1111/j.1349-7006.2006.00184.x

By:

Usami, Noriyasu;
Fukui, Takayuki;
Kondo, Masashi;
Taniguchi, Tetsuo;
Yokoyama, Toshihiko;
Mori, Shoichi;
Yokoi, Kohei;
Horio, Yoshitsugu;
Shimokata, Kaoru;
Sekido, Yoshitaka;
Hida, Toyoaki

Publication type:

Article

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 237, doi. 10.1007/s00280-009-1151-1

By:

Yoshitsugu Horio;
Osada, Hirotaka;
Shimizu, Junichi;
Ogawa, Shizu;
Hida, Toyoaki;
Sekido, Yoshitaka

Publication type:

Article

Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumors.

Published in:

2004

By:

Saeki, Toshiaki;
Eguchi, Kenji;
Takashima, Shigemitu;
Sugiura, Takahiko;
Hida, Toyoaki;
Horikoshi, Noboru;
Aiba, Keisuke;
Kuwabara, Takashi;
Ogawa, Makoto

Publication type:

journal article

Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF.

Published in:

Pathology International, 2020, v. 70, n. 5, p. 253, doi. 10.1111/pin.12903

By:

Seto, Katsutoshi;
Haneda, Masataka;
Masago, Katsuhiro;
Fujita, Shiro;
Kato, Seiichi;
Sasaki, Eiichi;
Hosoda, Waki;
Murakami, Yoshiko;
Kuroda, Hiroaki;
Horio, Yoshitsugu;
Hida, Toyoaki;
Okubo, Kenichi;
Yatabe, Yasushi

Publication type:

Article

Anaplastic lymphoma kinase expression in small‐cell lung cancer.

Published in:

Histopathology, 2019, v. 75, n. 1, p. 20, doi. 10.1111/his.13842

By:

Kondoh, Chiaki;
Horio, Yoshitsugu;
Hayashi, Yuko;
Ebi, Hiromichi;
Hida, Toyoaki;
Hasegawa, Yoshinori;
Yatabe, Yasushi

Publication type:

Article

Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

Published in:

Oncogene, 2001, v. 20, n. 31, p. 4249, doi. 10.1038/sj.onc.1204557

By:

Shigemitsu, Kikuo;
Sekido, Yoshitaka;
Usami, Noriyasu;
Mori, Shoichi;
Sato, Mitsuo;
Horio, Yoshitsugu;
Hasegawa, Yoshinori;
Bader, Scott A;
Gazdar, Adi F;
Minna, John D;
Hida, Toyoaki;
Yoshioka, Hiromu;
Imaizumi, Munehisa;
Ueda, Yuichi;
Takahashi, Masahide;
Shimokata, Kaoru

Publication type:

Article

Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis.

Published in:

Oncogene, 2001, v. 20, n. 31, p. 4228, doi. 10.1038/sj.onc.1204561

By:

Kozaki, Ken-ichi;
Koshikawa, Katsumi;
Tatematsu, Yoshio;
Miyaishi, Osamu;
Saito, Hiroko;
Hida, Toyoaki;
Osada, Hirotaka;
Takahashi, Takashi

Publication type:

Article

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study.

Published in:

Cancers, 2021, v. 13, n. 11, p. 2531, doi. 10.3390/cancers13112531

By:

Kuroda, Hiroaki;
Sugita, Yusuke;
Masago, Katsuhiro;
Takahashi, Yusuke;
Nakada, Takeo;
Sasaki, Eiichi;
Sakakura, Noriaki;
Yamaguchi, Rui;
Matsushita, Hirokazu;
Hida, Toyoaki

Publication type:

Article

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.

Published in:

2020

By:

Papadimitrakopoulou, Vassiliki A.;
Han, Ji‐Youn;
Ahn, Myung‐Ju;
Ramalingam, Suresh S.;
Delmonte, Angelo;
Hsia, Te‐Chun;
Laskin, Janessa;
Kim, Sang‐We;
He, Yong;
Tsai, Chun‐Ming;
Hida, Toyoaki;
Maemondo, Makoto;
Kato, Terufumi;
Jenkins, Suzanne;
Patel, Sabina;
Huang, Xiangning;
Laus, Gianluca;
Markovets, Aleksandra;
Thress, Kenneth S.;
Wu, Yi‐Long

Publication type:

journal article